{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:59:23Z","timestamp":1791320363538,"version":"4.3.1"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T00:00:00Z","timestamp":1605916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic kidney diseases (CKD) are associated with mineral and bone diseases (MBD), including pain, bone loss, and fractures. Bone fragility related to CKD includes the risk factors observed in osteoporosis in addition to those related to CKD, resulting in a higher risk of mortality related to fractures. Unawareness of such complications led to a poor management of fractures and a lack of preventive approaches. The current guidelines of the Kidney Disease Improving Global Outcomes (KDIGO) recommend the assessment of bone mineral density if results will impact treatment decision. In addition to bone density, circulating biomarkers of mineral, serum bone turnover markers, and imaging techniques are currently available to evaluate the fracture risk. The purpose of this review is to provide an overview of the epidemiology and pathogenesis of CKD-associated bone loss. The contribution of the current tools and other techniques in development are discussed. We here propose a current view of how to better predict bone fragility and the therapeutic options in CKD.<\/jats:p>","DOI":"10.1007\/s00223-020-00779-z","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T11:02:31Z","timestamp":1605956551000},"page":"539-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Bone Fragility Fractures in CKD Patients"],"prefix":"10.1007","volume":"108","author":[{"given":"Ana","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ure\u00f1a-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Luis Fernandez-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8582-8258","authenticated-orcid":false,"given":"Martine","family":"Cohen-Solal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,21]]},"reference":[{"key":"779_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1681\/ASN.2012090916","volume":"24","author":"AC Beaubrun","year":"2013","unstructured":"Beaubrun AC, Kilpatrick RD, Freburger JK et al (2013) Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol 24:1461\u20131469. https:\/\/doi.org\/10.1681\/ASN.2012090916","journal-title":"J Am Soc Nephrol"},{"key":"779_CR2","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/ndt\/gfw073","volume":"31","author":"D Hansen","year":"2016","unstructured":"Hansen D, Olesen JB, Gislason GH et al (2016) Risk of fracture in adults on renal replacement therapy: a Danish national cohort study. Nephrol Dial Transplant 31:1654\u20131662. https:\/\/doi.org\/10.1093\/ndt\/gfw073","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","volume":"25","author":"M Maravic","year":"2014","unstructured":"Maravic M, Ostertag A, Torres PU, Cohen-Solal M (2014) Incidence and risk factors for hip fractures in dialysis patients. Osteoporos Int 25:159\u2013165. https:\/\/doi.org\/10.1007\/s00198-013-2435-1","journal-title":"Osteoporos Int"},{"key":"779_CR4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ki.2013.279","volume":"85","author":"F Tentori","year":"2014","unstructured":"Tentori F, McCullough K, Kilpatrick RD et al (2014) High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int 85:166\u2013173. https:\/\/doi.org\/10.1038\/ki.2013.279","journal-title":"Kidney Int"},{"key":"779_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","volume":"47","author":"MD Danese","year":"2006","unstructured":"Danese MD, Kim J, Doan QV et al (2006) PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. Am J Kidney Dis 47:149\u2013156. https:\/\/doi.org\/10.1053\/j.ajkd.2005.09.024","journal-title":"Am J Kidney Dis"},{"key":"779_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92:26\u201336. https:\/\/doi.org\/10.1016\/j.kint.2017.04.006","journal-title":"Kidney Int"},{"key":"779_CR7","unstructured":"Group KDIGOC-MW (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl S1"},{"key":"779_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamainternmed.2020.2986","volume":"180","author":"CJ Crandall","year":"2020","unstructured":"Crandall CJ, Larson J, Wright NC et al (2020) Serial bone density measurement and incident fracture risk discrimination in postmenopausal women. JAMA Intern Med 180:1232\u20131240. https:\/\/doi.org\/10.1001\/jamainternmed.2020.2986","journal-title":"JAMA Intern Med"},{"key":"779_CR9","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"A Alem","year":"2000","unstructured":"Alem A, Sherrard D, Gillen D et al (2000) Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396\u2013399. https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00178.x","journal-title":"Kidney Int"},{"key":"779_CR10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/j.1532-5415.2008.01807.x","volume":"56","author":"AZ LaCroix","year":"2008","unstructured":"LaCroix AZ, Lee JS, Wu L et al (2008) Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 56:1434\u20131441. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01807.x","journal-title":"J Am Geriatr Soc"},{"key":"779_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","volume":"43","author":"C Ambrus","year":"2011","unstructured":"Ambrus C, Almasi C, Berta K et al (2011) Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis. Int Urol Nephrol 43:475\u2013482. https:\/\/doi.org\/10.1007\/s11255-010-9723-x","journal-title":"Int Urol Nephrol"},{"key":"779_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/ndt\/gfr317","volume":"27","author":"S Iimori","year":"2012","unstructured":"Iimori S, Mori Y, Akita W et al (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single-center cohort study. Nephrol Dial Transplant 27:345\u2013351. https:\/\/doi.org\/10.1093\/ndt\/gfr317","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00774-012-0411-z","volume":"31","author":"M Wakasugi","year":"2013","unstructured":"Wakasugi M, Kazama JJ, Taniguchi M et al (2013) Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Miner Metab 31:315\u2013321. https:\/\/doi.org\/10.1007\/s00774-012-0411-z","journal-title":"J Bone Miner Metab"},{"key":"779_CR14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1053\/j.ajkd.2013.02.368","volume":"62","author":"TJ Arneson","year":"2013","unstructured":"Arneson TJ, Li S, Liu J et al (2013) Trends in hip fracture rates in US hemodialysis patients, 1993\u20132010. Am J Kidney Dis 62:747\u2013754. https:\/\/doi.org\/10.1053\/j.ajkd.2013.02.368","journal-title":"Am J Kidney Dis"},{"key":"779_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2215\/CJN.09130912","volume":"8","author":"MJ Elliott","year":"2013","unstructured":"Elliott MJ, James MT, Quinn RR et al (2013) Estimated GFR and fracture risk: a population-based study. Clin J Am Soc Nephrol 8:1367\u20131376. https:\/\/doi.org\/10.2215\/CJN.09130912","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR16","doi-asserted-by":"publisher","unstructured":"Nair SS, Mitani AA, Goldstein BA et al (2013) Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States. Clin J Am Soc Nephrol 8:1336\u20131342.https:\/\/doi.org\/10.2215\/CJN.10901012","DOI":"10.2215\/CJN.10901012"},{"key":"779_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000369039","volume":"40","author":"AT Mathew","year":"2014","unstructured":"Mathew AT, Hazzan A, Jhaveri KD et al (2014) Increasing hip fractures in patients receiving hemodialysis and peritoneal dialysis. Am J Nephrol 40:451\u2013457. https:\/\/doi.org\/10.1159\/000369039","journal-title":"Am J Nephrol"},{"key":"779_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000439000","volume":"42","author":"C Delgado","year":"2015","unstructured":"Delgado C, Shieh S, Grimes B et al (2015) Association of self-reported frailty with falls and fractures among patients new to dialysis. Am J Nephrol 42:134\u2013140. https:\/\/doi.org\/10.1159\/000439000","journal-title":"Am J Nephrol"},{"key":"779_CR19","doi-asserted-by":"publisher","first-page":"e0122691","DOI":"10.1371\/journal.pone.0122691","volume":"10","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Kido R, Onishi Y et al (2015) Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients. PLoS ONE 10:e0122691. https:\/\/doi.org\/10.1371\/journal.pone.0122691","journal-title":"PLoS ONE"},{"key":"779_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","volume":"36","author":"M Coco","year":"2000","unstructured":"Coco M, Rush H (2000) Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115\u20131121. https:\/\/doi.org\/10.1053\/ajkd.2000.19812","journal-title":"Am J Kidney Dis"},{"key":"779_CR21","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/j.1523-1755.2000.00394.x","volume":"58","author":"CO Stehman-Breen","year":"2000","unstructured":"Stehman-Breen CO, Sherrard DJ, Alem AM et al (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200\u20132205","journal-title":"Kidney Int"},{"key":"779_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1007\/s00198-005-1903-7","volume":"16","author":"L Dukas","year":"2005","unstructured":"Dukas L, Schacht E, St\u00e4helin HB (2005) In elderly men and women treated for osteoporosis a low creatinine clearance of <65 ml\/min is a risk factor for falls and fractures. Osteoporos Int 16:1683\u20131690. https:\/\/doi.org\/10.1007\/s00198-005-1903-7","journal-title":"Osteoporos Int"},{"key":"779_CR23","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"Jadoul M, Albert JM, Akiba T et al (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 70:1358\u20131366. https:\/\/doi.org\/10.1038\/sj.ki.5001754","journal-title":"Kidney Int"},{"key":"779_CR24","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1681\/ASN.2005111194","volume":"17","author":"TL Nickolas","year":"2006","unstructured":"Nickolas TL, McMahon DJ, Shane E (2006) Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223\u20133232. https:\/\/doi.org\/10.1681\/ASN.2005111194","journal-title":"J Am Soc Nephrol"},{"key":"779_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1001\/archinte.167.2.133","volume":"167","author":"KE Ensrud","year":"2007","unstructured":"Ensrud KE, Lui L-Y, Taylor BC et al (2007) Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133. https:\/\/doi.org\/10.1001\/archinte.167.2.133","journal-title":"Arch Intern Med"},{"key":"779_CR26","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1681\/ASN.2006050546","volume":"18","author":"LF Fried","year":"2007","unstructured":"Fried LF, Biggs ML, Shlipak MG et al (2007) Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol 18:282\u2013286. https:\/\/doi.org\/10.1681\/ASN.2006050546","journal-title":"J Am Soc Nephrol"},{"key":"779_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","volume":"51","author":"AC Dooley","year":"2008","unstructured":"Dooley AC, Weiss NS, Kestenbaum B (2008) Increased risk of hip fracture among men with CKD. Am J Kidney Dis 51:38\u201344. https:\/\/doi.org\/10.1053\/j.ajkd.2007.08.019","journal-title":"Am J Kidney Dis"},{"key":"779_CR28","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06040614","author":"KL Naylor","year":"2015","unstructured":"Naylor KL, Garg AX, Zou G et al (2015) Comparison of fracture risk prediction among individuals with reduced and normal kidney function. Clin J Am Soc Nephrol. https:\/\/doi.org\/10.2215\/CJN.06040614","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR29","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"Naylor KL, McArthur E, Leslie WD et al (2014) The three-year incidence of fracture in chronic kidney disease. Kidney Int 86:810\u2013818. https:\/\/doi.org\/10.1038\/ki.2013.547","journal-title":"Kidney Int"},{"key":"779_CR30","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s00198-015-3429-y","volume":"27","author":"M Maravic","year":"2016","unstructured":"Maravic M, Ostertag A, Urena P, Cohen-Solal M (2016) Dementia is a major risk factor for hip fractures in patients with chronic kidney disease. Osteoporos Int 27:1665\u20131669. https:\/\/doi.org\/10.1007\/s00198-015-3429-y","journal-title":"Osteoporos Int"},{"key":"779_CR31","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573. https:\/\/doi.org\/10.1001\/jama.2009.1462","journal-title":"JAMA"},{"key":"779_CR32","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00198-020-05351-x","volume":"31","author":"IJA de Bruin","year":"2020","unstructured":"de Bruin IJA, Wyers CE, Souverein PC et al (2020) The risk of new fragility fractures in patients with chronic kidney disease and hip fracture\u2014a population-based cohort study in the UK. Osteoporos Int 31:1487\u20131497. https:\/\/doi.org\/10.1007\/s00198-020-05351-x","journal-title":"Osteoporos Int"},{"key":"779_CR33","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/jbmr.3997","volume":"35","author":"SH Kim","year":"2020","unstructured":"Kim SH, Yi SW, Yi JJ et al (2020) Chronic kidney disease increases the risk of hip fracture: a prospective cohort study in Korean adults. J Bone Miner Res 35:1313\u20131321. https:\/\/doi.org\/10.1002\/jbmr.3997","journal-title":"J Bone Miner Res"},{"key":"779_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1684","author":"NC Wright","year":"2012","unstructured":"Wright NC, Saag KG, Curtis JR et al (2012) Recent trends in hip fracture rates by race\/ethnicity among older US adults. J Bone Miner Res. https:\/\/doi.org\/10.1002\/jbmr.1684","journal-title":"J Bone Miner Res"},{"key":"779_CR35","doi-asserted-by":"crossref","unstructured":"Ball AM, Gillen DL, Weiss NS, et al (2002) Risk of hip fracture among dialysis and renal transplant recipients. J Am Med Assoc 288:3014\u20133018","DOI":"10.1001\/jama.288.23.3014"},{"key":"779_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0272-6386(99)70302-1","volume":"33","author":"K Atsumi","year":"1999","unstructured":"Atsumi K, Kushida K, Yamazaki K et al (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287\u2013293. https:\/\/doi.org\/10.1016\/S0272-6386(99)70302-1","journal-title":"Am J Kidney Dis"},{"key":"779_CR37","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","volume":"18","author":"P Ure\u00f1a","year":"2003","unstructured":"Ure\u00f1a P, Bernard-Poenaru O, Ostertag A et al (2003) Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant 18:2325\u20132331","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR38","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"Moe SM, Abdalla S, Chertow GM et al (2015) Effects of cinacalcet on fracture events in patients receiving hemodialysis: The EVOLVE trial. J Am Soc Nephrol 26:1466\u20131475. https:\/\/doi.org\/10.1681\/ASN.2014040414","journal-title":"J Am Soc Nephrol"},{"key":"779_CR39","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3390\/jcm9051604","volume":"9","author":"C Castro-Alonso","year":"2020","unstructured":"Castro-Alonso C, D\u2019Marco L, Pomes J et al (2020) Prevalence of vertebral fractures and their prognostic significance in the survival in patients with chronic kidney disease stages 3\u20135 not on dialysis. J Clin Med 9:1604. https:\/\/doi.org\/10.3390\/jcm9051604","journal-title":"J Clin Med"},{"key":"779_CR40","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.annepidem.2006.12.004","volume":"17","author":"E Bass","year":"2007","unstructured":"Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17:514\u2013519. https:\/\/doi.org\/10.1016\/j.annepidem.2006.12.004","journal-title":"Ann Epidemiol"},{"key":"779_CR41","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1046\/j.1532-5415.2002.50163.x","volume":"50","author":"M Fransen","year":"2002","unstructured":"Fransen M, Woodward M, Norton R et al (2002) Excess mortality or institutionalization after hip fracture: Men are at greater risk than women. J Am Geriatr Soc 50:685\u2013690. https:\/\/doi.org\/10.1046\/j.1532-5415.2002.50163.x","journal-title":"J Am Geriatr Soc"},{"key":"779_CR42","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/ndt\/gfn678","volume":"24","author":"D Nitsch","year":"2009","unstructured":"Nitsch D, Mylne A, Roderick PJ et al (2009) Chronic kidney disease and hip fracture-related mortality in older people in the UK. Nephrol Dial Transplant 24:1539\u20131544. https:\/\/doi.org\/10.1093\/ndt\/gfn678","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00198-014-2813-3","volume":"26","author":"RC Bucur","year":"2015","unstructured":"Bucur RC, Panjwani DD, Turner L et al (2015) Low bone mineral density and fractures in stages 3\u20135 CKD: an updated systematic review and meta-analysis. Osteoporos Int 26:449\u2013458. https:\/\/doi.org\/10.1007\/s00198-014-2813-3","journal-title":"Osteoporos Int"},{"key":"779_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jbmr.2406","volume":"30","author":"SL West","year":"2015","unstructured":"West SL, Lok CE, Langsetmo L et al (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res 30:913\u2013919. https:\/\/doi.org\/10.1002\/jbmr.2406","journal-title":"J Bone Miner Res"},{"key":"779_CR45","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2215\/CJN.12871211","volume":"7","author":"RH Yenchek","year":"2012","unstructured":"Yenchek RH, Ix JH, Shlipak MG et al (2012) Bone mineral density and fracture risk in older individuals with CKD. Clin J Am Soc Nephrol 7:1130\u20131136. https:\/\/doi.org\/10.2215\/CJN.12871211","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1359\/jbmr.060105","volume":"21","author":"SA Jamal","year":"2006","unstructured":"Jamal SA, Gilbert J, Gordon C, Bauer DC (2006) Cortical pQCT measures are associated with fractures in dialysis patients. J Bone Min Res 21:543\u2013548. https:\/\/doi.org\/10.1359\/jbmr.060105","journal-title":"J Bone Min Res"},{"key":"779_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00198-013-2524-1","volume":"25","author":"SA Jamal","year":"2014","unstructured":"Jamal SA, West SL, Nickolas TL (2014) The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int 25:71\u201376. https:\/\/doi.org\/10.1007\/s00198-013-2524-1","journal-title":"Osteoporos Int"},{"key":"779_CR48","doi-asserted-by":"publisher","unstructured":"Przedlacki J, Buczy\u0144ska-Chyl J, Ko\u017ami\u0144ski P et al (2020) FRAX prognostic and intervention thresholds in the management of major bone fractures in hemodialysis patients: A two-year prospective multicenter cohort study. Bone 133. doi:https:\/\/doi.org\/10.1016\/j.bone.2019.115188","DOI":"10.1016\/j.bone.2019.115188"},{"key":"779_CR49","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz195","author":"J Aleksova","year":"2019","unstructured":"Aleksova J, Milat F, Kotowicz MA et al (2019) Patients with end-stage kidney disease have markedly abnormal cortical hip parameters by dual-energy X-ray absorptiometry. Nephrol Dial Transplant. https:\/\/doi.org\/10.1093\/ndt\/gfz195","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR50","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1002\/jbmr.2241","volume":"29","author":"TL Bredbenner","year":"2014","unstructured":"Bredbenner TL, Mason RL, Havill LM et al (2014) Fracture risk predictions based on statistical shape and density modeling of the proximal femur. J Bone Miner Res 29:2090\u20132100. https:\/\/doi.org\/10.1002\/jbmr.2241","journal-title":"J Bone Miner Res"},{"key":"779_CR51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1210\/clinem\/dgz060","volume":"105","author":"L Gracia-Marco","year":"2020","unstructured":"Gracia-Marco L, Garc\u00eda-Fontana B, Ubago-Guisado E et al (2020) Analysis of bone impairment by 3D DXA hip measures in patients with primary hyperparathyroidism: a pilot study. J Clin Endocrinol Metab 105:175\u2013180. https:\/\/doi.org\/10.1210\/clinem\/dgz060","journal-title":"J Clin Endocrinol Metab"},{"key":"779_CR52","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","volume":"31","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Od\u00e9n A, Harvey NC et al (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31:940\u2013948. https:\/\/doi.org\/10.1002\/jbmr.2734","journal-title":"J Bone Miner Res"},{"key":"779_CR53","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.00720116","volume":"11","author":"KL Naylor","year":"2016","unstructured":"Naylor KL, Prior J, Garg AX et al (2016) Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function. Clin J Am Soc Nephrol 11:2032\u20132040. https:\/\/doi.org\/10.2215\/CJN.00720116","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR54","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.309","volume":"26","author":"HH Malluche","year":"2011","unstructured":"Malluche HH, Mawad HW, Monier-Faugere MC (2011) Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Miner Res 26:1368\u20131376. https:\/\/doi.org\/10.1002\/jbmr.309","journal-title":"J Bone Miner Res"},{"key":"779_CR55","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","volume":"28","author":"TL Nickolas","year":"2013","unstructured":"Nickolas TL, Stein EM, Dworakowski E et al (2013) Rapid cortical bone loss in patients with chronic kidney disease. J Bone Min Res 28:1811\u20131820. https:\/\/doi.org\/10.1002\/jbmr.1916","journal-title":"J Bone Min Res"},{"key":"779_CR56","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.2215\/CJN.09470913","volume":"9","author":"HH Malluche","year":"2014","unstructured":"Malluche HH, Davenport DL, Canto T, Monier-Faugere MC (2014) Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis. Clin J Am Soc Nephrol 9:1254\u20131262. https:\/\/doi.org\/10.2215\/CJN.09470913","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR57","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0021-9290(03)00174-X","volume":"37","author":"K Hasegawa","year":"2004","unstructured":"Hasegawa K, Hasegawa Y, Nagano A (2004) Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography. J Biomech 37:751\u2013756. https:\/\/doi.org\/10.1016\/S0021-9290(03)00174-X","journal-title":"J Biomech"},{"key":"779_CR58","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.2215\/CJN.09711010","volume":"6","author":"D Cejka","year":"2011","unstructured":"Cejka D, Patsch JM, Weber M et al (2011) Bone microarchitecture in hemodialysis patients assessed by HR-pQCT. Clin J Am Soc Nephrol 6:2264\u20132271. https:\/\/doi.org\/10.2215\/CJN.09711010","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11154-015-9314-3","volume":"16","author":"TL Nickolas","year":"2015","unstructured":"Nickolas TL, Jamal SA (2015) Bone kidney interactions. Rev Endocr Metab Disord 16:157\u2013163. https:\/\/doi.org\/10.1007\/s11154-015-9314-3","journal-title":"Rev Endocr Metab Disord"},{"key":"779_CR60","doi-asserted-by":"publisher","first-page":"090923081446048","DOI":"10.1359\/jbmr.090831","volume":"25","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Boutroy S, Vilayphiou N et al (2009) Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 25:090923081446048\u201324. https:\/\/doi.org\/10.1359\/jbmr.090831","journal-title":"J Bone Miner Res"},{"key":"779_CR61","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04810515","volume":"11","author":"RC Pereira","year":"2016","unstructured":"Pereira RC, Bischoff DS, Yamaguchi D et al (2016) Micro-CT in the assessment of pediatric renal osteodystrophy by bone histomorphometry. Clin J Am Soc Nephrol 11:481\u2013487. https:\/\/doi.org\/10.2215\/CJN.04810515","journal-title":"Clin J Am Soc Nephrol"},{"key":"779_CR62","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1159\/000510064","volume":"51","author":"E Benillouche","year":"2020","unstructured":"Benillouche E, Ostertag A, Marty C et al (2020) Cortical bone microarchitecture in dialysis patients. Am J Nephrol 51:833\u2013838. https:\/\/doi.org\/10.1159\/000510064","journal-title":"Am J Nephrol"},{"key":"779_CR63","doi-asserted-by":"publisher","unstructured":"Marques IDB, Ara\u00fajo MJCLN, Graciolli FG et al (2017) Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities. Osteoporos Int 28:1675\u20131683. doi:https:\/\/doi.org\/10.1007\/s00198-017-3956-9","DOI":"10.1007\/s00198-017-3956-9"},{"key":"779_CR64","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1359\/jbmr.2002.17.8.1372","volume":"17","author":"S Nuzzo","year":"2002","unstructured":"Nuzzo S, Lafage-Proust MH, Martin-Badosa E et al (2002) Synchrotron radiation microtomography allows the analysis of three-dimensional microarchitecture and degree of mineralization of human iliac crest biopsy specimens: effects of etidronate treatment. J Bone Miner Res 17:1372\u20131382. https:\/\/doi.org\/10.1359\/jbmr.2002.17.8.1372","journal-title":"J Bone Miner Res"},{"key":"779_CR65","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jbmr.2324","volume":"30","author":"B Hesse","year":"2015","unstructured":"Hesse B, Varga P, Langer M et al (2015) Canalicular network morphology is the major determinant of the spatial distribution of mass density in human bone tissue: Evidence by means of synchrotron radiation phase-contrast nano-CT. J Bone Miner Res 30:346\u2013356. https:\/\/doi.org\/10.1002\/jbmr.2324","journal-title":"J Bone Miner Res"},{"key":"779_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0171873","volume":"12","author":"B Bielesz","year":"2017","unstructured":"Bielesz B, Patsch JM, Fischer L et al (2017) Cortical porosity not superior to conventional densitometry in identifying hemodialysis patients with fragility fracture. PLoS ONE 12:1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0171873","journal-title":"PLoS ONE"},{"key":"779_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000045968","volume":"88","author":"J Heaf","year":"2001","unstructured":"Heaf J (2001) Causes and consequences of adynamic bone disease. Nephron 88:97\u2013106.","journal-title":"Nephron"},{"key":"779_CR68","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR et al (2015) Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int 87:846\u2013856. https:\/\/doi.org\/10.1038\/ki.2014.349","journal-title":"Kidney Int"},{"key":"779_CR69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/sj.ki.5002769","volume":"73","author":"FC Barreto","year":"2008","unstructured":"Barreto FC, Barreto DV, Moys\u00e9s RMA et al (2008) K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 73:771\u2013777. https:\/\/doi.org\/10.1038\/sj.ki.5002769","journal-title":"Kidney Int"},{"key":"779_CR70","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/ndt\/gft290","volume":"28","author":"P Lertdumrongluk","year":"2013","unstructured":"Lertdumrongluk P, Lau WL, Park J et al (2013) Impact of age on survival predictability of bone turnover markers in hemodialysis patients. Nephrol Dial Transplant 28:2535\u20132545. https:\/\/doi.org\/10.1093\/ndt\/gft290","journal-title":"Nephrol Dial Transplant"},{"key":"779_CR71","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.ajkd.2012.10.002","volume":"61","author":"DS Fuller","year":"2013","unstructured":"Fuller DS, Pisoni RL, Bieber BA et al (2013) The DOPPS practice monitor for US dialysis care: trends through December 2011. Am J Kidney Dis 61:342\u2013346. https:\/\/doi.org\/10.1053\/j.ajkd.2012.10.002","journal-title":"Am J Kidney Dis"},{"key":"779_CR72","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/ajkd.2002.33398","volume":"39","author":"J-Y Guh","year":"2002","unstructured":"Guh J-Y, Chen H-C, Chuang H-Y et al (2002) Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis 39:1245\u20131254. https:\/\/doi.org\/10.1053\/ajkd.2002.33398","journal-title":"Am J Kidney Dis"},{"key":"779_CR73","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2265.2011.04265.x","volume":"76","author":"K-C Lu","year":"2012","unstructured":"Lu K-C, Ma W-Y, Yu J-C et al (2012) Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Clin Endocrinol (Oxf) 76:634\u2013642. https:\/\/doi.org\/10.1111\/j.1365-2265.2011.04265.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"779_CR74","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1002\/jbmr.126","volume":"25","author":"A Yajima","year":"2010","unstructured":"Yajima A, Inaba M, Tominaga Y et al (2010) Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism. J Bone Miner Res 25:2374\u20132381. https:\/\/doi.org\/10.1002\/jbmr.126","journal-title":"J Bone Miner Res"},{"key":"779_CR75","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1681\/ASN.2007010022","volume":"18","author":"KD Rudser","year":"2007","unstructured":"Rudser KD, de Boer IH, Dooley A et al (2007) Fracture risk after parathyroidectomy among chronic hemodialysis patients. J Am Soc Nephrol 18:2401\u20132407. https:\/\/doi.org\/10.1681\/ASN.2007010022","journal-title":"J Am Soc Nephrol"},{"key":"779_CR76","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1681\/ASN.2017050584","volume":"29","author":"S Salam","year":"2018","unstructured":"Salam S, Gallagher O, Gossiel F et al (2018) Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy. J Am Soc Nephrol 29:1557\u20131565. https:\/\/doi.org\/10.1681\/ASN.2017050584","journal-title":"J Am Soc Nephrol"},{"key":"779_CR77","doi-asserted-by":"publisher","unstructured":"Nickolas TL, Chen N, McMahon DJ et al (2020) A microRNA approach to discriminate cortical low bone turnover in renal osteodystrophy. JBMR Plus 4. doi:https:\/\/doi.org\/10.1002\/jbm4.10353","DOI":"10.1002\/jbm4.10353"},{"key":"779_CR78","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ki.2008.643","volume":"75","author":"D Pri\u00e9","year":"2009","unstructured":"Pri\u00e9 D, Torres PU, Friedlander G (2009) Latest findings in phosphate homeostasis. Kidney Int 75:882\u2013889. https:\/\/doi.org\/10.1038\/ki.2008.643","journal-title":"Kidney Int"},{"key":"779_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.3094","volume":"32","author":"N Campos-Obando","year":"2017","unstructured":"Campos-Obando N, Koek WNH, Hooker ER et al (2017) Serum phosphate is associated with fracture risk: the Rotterdam study and MrOS. J Bone Miner Res 32:1\u201312. https:\/\/doi.org\/10.1002\/jbmr.3094","journal-title":"J Bone Miner Res"},{"key":"779_CR80","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A215\/8\/2208[pii]","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218. https:\/\/doi.org\/10.1097\/01.ASN.0000133041.27682.A215\/8\/2208[pii]","journal-title":"J Am Soc Nephrol"},{"key":"779_CR81","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/cen.13363","volume":"87","author":"J Aleksova","year":"2017","unstructured":"Aleksova J, Wong P, Mulley WR et al (2017) Serum phosphorus levels and fracture following renal transplantation. Clin Endocrinol (Oxf) 87:141\u2013148. https:\/\/doi.org\/10.1111\/cen.13363","journal-title":"Clin Endocrinol (Oxf)"},{"key":"779_CR82","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.kint.2016.04.024","volume":"90","author":"NA Dhayat","year":"2016","unstructured":"Dhayat NA, Ackermann D, Pruijm M et al (2016) Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90:648\u2013657. https:\/\/doi.org\/10.1016\/j.kint.2016.04.024","journal-title":"Kidney Int"},{"key":"779_CR83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/sj.ki.5002622","volume":"73","author":"P Urena Torres","year":"2008","unstructured":"Urena Torres P, Friedlander G, de Vernejoul MC et al (2008) Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73:102\u2013107. https:\/\/doi.org\/10.1038\/sj.ki.5002622","journal-title":"Kidney Int"},{"key":"779_CR84","doi-asserted-by":"publisher","unstructured":"Ribeiro AL, Mendes F, Carias E et al (2020) FGF23-klotho axis as predictive factors of fractures in type 2 diabetics with early chronic kidney disease. J Diabetes Complications 34https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.107476","DOI":"10.1016\/j.jdiacomp.2019.107476"},{"key":"779_CR85","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00467-012-2110-3","volume":"27","author":"J Bacchetta","year":"2012","unstructured":"Bacchetta J, Cochat P, Salusky IB, Wesseling-Perry K (2012) Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function. Pediatr Nephrol 27:1131\u20131138. https:\/\/doi.org\/10.1007\/s00467-012-2110-3","journal-title":"Pediatr Nephrol"},{"key":"779_CR86","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-L\u00f3pez","year":"2016","unstructured":"Carrillo-L\u00f3pez N, Panizo S, Alonso-Montes C et al (2016) Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int 90:77\u201389. https:\/\/doi.org\/10.1016\/j.kint.2016.01.024","journal-title":"Kidney Int"},{"key":"779_CR87","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953. https:\/\/doi.org\/10.1038\/sj.ki.5000414","journal-title":"Kidney Int"},{"key":"779_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/sj.ki.5002009","volume":"71","author":"A Levin","year":"2006","unstructured":"Levin A, Bakris GL, Molitch M et al (2006) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31\u201338. https:\/\/doi.org\/10.1038\/sj.ki.5002009","journal-title":"Kidney Int"},{"key":"779_CR89","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1681\/ASN.2008020159","volume":"20","author":"O Moranne","year":"2009","unstructured":"Moranne O, Froissart M, Rossert J et al (2009) Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol 20:164\u2013171. https:\/\/doi.org\/10.1681\/ASN.2008020159","journal-title":"J Am Soc Nephrol"},{"key":"779_CR90","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5414\/CNP70296","volume":"70","author":"G Lehmann","year":"2008","unstructured":"Lehmann G, Ott U, Kaemmerer D et al (2008) Bone histomorphometry and biochemical markers of bone turnover in patients with chronic kidney disease stages 3\u20135. Clin Nephrol 70:296\u2013305","journal-title":"Clin Nephrol"},{"key":"779_CR91","doi-asserted-by":"publisher","unstructured":"Spasovski GB, Bervoets AR, Behets GJ et al (2003) Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis. Nephrol Dial Transpl 18:1159\u20131166. doi:https:\/\/doi.org\/10.1093\/ndt\/gfg116","DOI":"10.1093\/ndt\/gfg116"},{"key":"779_CR92","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1359\/jbmr.090735","volume":"25","author":"C Tomiyama","year":"2010","unstructured":"Tomiyama C, Carvalho AB, Higa A et al (2010) Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment. J Bone Miner Res 25:499\u2013504. https:\/\/doi.org\/10.1359\/jbmr.090735","journal-title":"J Bone Miner Res"},{"key":"779_CR93","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Bellorin-Font E, Jorgetti V et al (2016) Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am J Kidney Dis 67:559\u2013566. https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.023","journal-title":"Am J Kidney Dis"},{"key":"779_CR94","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","volume":"89","author":"TB Dr\u00fceke","year":"2016","unstructured":"Dr\u00fceke TB, Massy ZA (2016) Changing bone patterns with progression of chronic kidney disease. Kidney Int 89:289\u2013302. https:\/\/doi.org\/10.1016\/j.kint.2015.12.004","journal-title":"Kidney Int"},{"key":"779_CR95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/ki.2014.201","volume":"88","author":"C Hurtgen","year":"2015","unstructured":"Hurtgen C, Morelle J, Vande BB, Jadoul M (2015) The case | bilateral severe mechanical joint pain in the lower limbs in a hemodialysis patient. The diagnosis | hypophosphatemia-induced osteomalacia. Kidney Int 88:207\u2013208. https:\/\/doi.org\/10.1038\/ki.2014.201","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"779_CR96","doi-asserted-by":"publisher","first-page":"S256","DOI":"10.1177\/089686080102103S45","volume":"21","author":"C Rodd","year":"2001","unstructured":"Rodd C (2001) Bisphosphonates in dialysis and transplantation patients: efficacy and safety issues. Perit Dial Int 21(Suppl 3):S256\u2013S260","journal-title":"Perit Dial Int"},{"key":"779_CR97","doi-asserted-by":"publisher","first-page":"649","DOI":"10.7326\/M16-2752","volume":"166","author":"LM Wilson","year":"2017","unstructured":"Wilson LM, Rebholz CM, Jirru E et al (2017) Benefits and harms of osteoporosis medications in patients with chronic kidney disease. Ann Intern Med 166:649. https:\/\/doi.org\/10.7326\/M16-2752","journal-title":"Ann Intern Med"},{"key":"779_CR98","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jbmr.403","volume":"26","author":"SA Jamal","year":"2011","unstructured":"Jamal SA, Ljunggren \u00d6, Stehman-Breen C et al (2011) Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26:1829\u20131835. https:\/\/doi.org\/10.1002\/jbmr.403","journal-title":"J Bone Miner Res"},{"key":"779_CR99","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/jbmr.3676","volume":"34","author":"K Iseri","year":"2019","unstructured":"Iseri K, Watanabe M, Yoshikawa H et al (2019) Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial. J Bone Miner Res 34:1014\u20131024. https:\/\/doi.org\/10.1002\/jbmr.3676","journal-title":"J Bone Miner Res"},{"key":"779_CR100","doi-asserted-by":"publisher","unstructured":"Chen NC, Hsu CY, Chen CL (2017) The strategy to prevent and regress the vascular calcification in dialysis patients. Biomed Res Int 2017.https:\/\/doi.org\/10.1155\/2017\/9035193","DOI":"10.1155\/2017\/9035193"},{"key":"779_CR101","doi-asserted-by":"publisher","first-page":"c3","DOI":"10.1159\/000075565","volume":"96","author":"R Fiedler","year":"2004","unstructured":"Fiedler R, Deuber HJ, Langer T et al (2004) Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients. Nephron - Clin Pract 96:c3\u2013c9. https:\/\/doi.org\/10.1159\/000075565","journal-title":"Nephron - Clin Pract"},{"key":"779_CR102","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/jbmr.2043","volume":"29","author":"EJ Samelson","year":"2014","unstructured":"Samelson EJ, Miller PD, Christiansen C et al (2014) RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res 29:450\u2013457. https:\/\/doi.org\/10.1002\/jbmr.2043","journal-title":"J Bone Miner Res"},{"key":"779_CR103","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2353\/ajpath.2009.080957","volume":"175","author":"S Helas","year":"2009","unstructured":"Helas S, Goettsch C, Schoppet M et al (2009) Inhibition of receptor activator of NF-\u03baB ligand by denosumab attenuates vascular calcium deposition in mice. Am J Pathol 175:473\u2013478. https:\/\/doi.org\/10.2353\/ajpath.2009.080957","journal-title":"Am J Pathol"},{"key":"779_CR104","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000316708","volume":"33","author":"D Cejka","year":"2010","unstructured":"Cejka D, Kodras K, Bader T, Haas M (2010) Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study. Kidney Blood Press Res 33:221\u2013226. https:\/\/doi.org\/10.1159\/000316708","journal-title":"Kidney Blood Press Res"},{"key":"779_CR105","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375:1532\u20131543. https:\/\/doi.org\/10.1056\/NEJMoa1607948","journal-title":"N Engl J Med"},{"key":"779_CR106","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.2372","volume":"30","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chen NX, Newman CL et al (2015) Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30:499\u2013509. https:\/\/doi.org\/10.1002\/jbmr.2372","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00779-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-020-00779-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00779-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T19:16:21Z","timestamp":1618600581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-020-00779-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,21]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00779-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,21]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Ana Pimentel, Pablo Ure\u00f1a-Torres, Jordi Bover, Jose Luis Fernandez-Mart\u00edn, and Martine Cohen-Sola declare that they have no conflicts of interest in relation to the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}